Cencora, Inc. $COR Shares Purchased by River Wealth Advisors LLC

River Wealth Advisors LLC raised its holdings in Cencora, Inc. (NYSE:COR) by 6.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 42,905 shares of the company’s stock after acquiring an additional 2,573 shares during the quarter. Cencora accounts for about 1.6% of River Wealth Advisors LLC’s holdings, making the stock its 17th biggest position. River Wealth Advisors LLC’s holdings in Cencora were worth $13,409,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in the stock. IAG Wealth Partners LLC acquired a new stake in shares of Cencora in the third quarter valued at about $30,000. Vermillion & White Wealth Management Group LLC increased its holdings in Cencora by 69.4% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock valued at $31,000 after buying an additional 43 shares in the last quarter. Cloud Capital Management LLC purchased a new position in Cencora in the third quarter valued at about $31,000. Caitlin John LLC acquired a new stake in shares of Cencora during the 3rd quarter valued at approximately $31,000. Finally, Westside Investment Management Inc. lifted its position in shares of Cencora by 200.0% during the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock valued at $33,000 after acquiring an additional 70 shares during the period. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms recently weighed in on COR. Jefferies Financial Group raised Cencora from an “underperform” rating to a “buy” rating in a research note on Thursday, January 22nd. Bank of America lowered their target price on Cencora from $380.00 to $360.00 and set a “neutral” rating on the stock in a report on Monday, January 5th. Mizuho raised their price target on Cencora from $340.00 to $380.00 and gave the company an “outperform” rating in a research report on Thursday, November 6th. Evercore decreased their price objective on shares of Cencora from $440.00 to $420.00 and set an “outperform” rating on the stock in a research report on Thursday, February 5th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Eleven analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $399.00.

Insider Buying and Selling

In other Cencora news, CEO Robert P. Mauch sold 5,096 shares of the business’s stock in a transaction on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total value of $1,807,704.08. Following the completion of the transaction, the chief executive officer directly owned 66,726 shares in the company, valued at approximately $23,669,713.98. The trade was a 7.10% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Silvana Battaglia sold 1,677 shares of the firm’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $345.00, for a total value of $578,565.00. Following the sale, the executive vice president owned 18,796 shares in the company, valued at $6,484,620. This trade represents a 8.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 15,220 shares of company stock worth $5,282,867. 0.38% of the stock is owned by insiders.

Cencora Stock Up 1.4%

Shares of NYSE:COR opened at $371.86 on Friday. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. The company has a market capitalization of $72.34 billion, a P/E ratio of 44.69, a P/E/G ratio of 1.73 and a beta of 0.68. Cencora, Inc. has a 52-week low of $248.59 and a 52-week high of $377.54. The stock’s fifty day simple moving average is $351.72 and its 200-day simple moving average is $333.89.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating the consensus estimate of $4.04 by $0.04. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The firm had revenue of $85.93 billion during the quarter, compared to the consensus estimate of $86.12 billion. During the same quarter in the previous year, the company posted $3.73 EPS. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. As a group, equities research analysts forecast that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Friday, February 13th will be paid a dividend of $0.60 per share. The ex-dividend date of this dividend is Friday, February 13th. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Cencora’s dividend payout ratio is presently 28.85%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.